Similar articles

• [Pulmonary involvement in systemic sclerosis].

  Ioanăş M. Ioanăş M. Pneumologia. 2002 Jul-Sep;51(3):230-3. Pneumologia. 2002. PMID: 12602096 Review. Romanian. No abstract available.
• Decrease in DL,CO in systemic sclerosis correlates with acceleration of DTPA clearance.

  Diot E, Giraudeau B, Maillot F, Diot P. Diot E, et al. Eur Respir J. 1999 Sep;14(3):728-9. doi: 10.1034/j.1399-3003.1999.14c42.x. Eur Respir J. 1999. PMID: 10543302 No abstract available.
• Biomarkers in systemic sclerosis.

  Castro SV, Jimenez SA. Castro SV, et al. Biomark Med. 2010 Feb;4(1):133-47. doi: 10.2217/bmm.09.79. Biomark Med. 2010. PMID: 20387310 Free PMC article. Review.
• [Transforming growth factor-beta and its receptors in scleroderma].

  QIAN H, ZHENG M. QIAN H, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Jul;38(4):415-21. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19693982 Review. Chinese.
• CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.

  Vorstenbosch J, Al-Ajmi H, Winocour S, Trzeciak A, Lessard L, Philip A. Vorstenbosch J, et al. Arthritis Rheum. 2013 May;65(5):1378-83. doi: 10.1002/art.37907. Arthritis Rheum. 2013. PMID: 23436317